Retraction Notice to "New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19" [Multiple Sclerosis and Related Disorders 57 (2022) 103321].

Authors :: Fragoso YD
Gomes S
Gonçalves MVM
Mendes JE
de Oliveira BES
Rocha CF
Cruz Dos Santos GA
Tauil CB
Araujo RV
Peron JPS
Source :: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2025 Jan 09; Vol. 94, pp. 106260. Date of Electronic Publication: 2025 Jan 09.
Publication Year :: 2025
Publisher :: Ahead of Print
Abstract: This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the authors. The authors would like to express their deepest apologies for the error contained in their article and for any concerns or misunderstandings it may have caused. Specifically, the article mistakenly mentioned the presence of the MF59 adjuvant in the AZD1222 vaccine formulation, which is incorrect.<br /> (Copyright © 2025 Elsevier B.V. All rights reserved.)

Full Text Access

Tools